News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Delayed response and survival from NovoTTF-100A in recurrent GBM

Al's Comment:

 A case report of a patient from the trial for recurrent GBMs, who has been on the device and doing well for 6 years.    Of note is his initial MRI after sterting the device looked worse. This shows that the device takes time to work and some people have been stopping too soon.


Posted on: 01/14/2013

   Delayed response and survival from NovoTTF-100A in recurrent GBM

Click HERE for the Full text as a PDF

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740